Detalhe da pesquisa
1.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423228
2.
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Breast Cancer Res
; 19(1): 44, 2017 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356166
3.
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Breast Cancer Res
; 17: 44, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882602
4.
Triple-negative breast cancer and the need for new therapeutic targets.
Am J Pathol
; 183(4): 1064-1074, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23920327
5.
Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.
BMC Cancer
; 14: 211, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24645668
6.
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
BMC Cancer
; 14: 845, 2014 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407022
7.
Improving breast cancer survival analysis through competition-based multidimensional modeling.
PLoS Comput Biol
; 9(5): e1003047, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23671412
8.
Copynumber: Efficient algorithms for single- and multi-track copy number segmentation.
BMC Genomics
; 13: 591, 2012 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23442169
9.
Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450379
10.
The breast cancer genome--a key for better oncology.
BMC Cancer
; 11: 501, 2011 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22128823
11.
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
; 10(1): 525, 2019 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30692535
12.
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
; 9(1): 5397, 2018 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559362
13.
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Genome Med
; 10(1): 92, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30497530
14.
Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.
Oncotarget
; 8(34): 57121-57133, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28915659
15.
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Nat Commun
; 8(1): 1221, 2017 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29089486
16.
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.
Clin Cancer Res
; 23(16): 4662-4670, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28487444
17.
The importance of gene-centring microarray data.
Lancet Oncol
; 11(8): 719-20; author reply 720-1, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20688275
18.
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.
Nat Commun
; 7: 11479, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27161491
19.
The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.
PLoS One
; 10(10): e0139965, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460974
20.
Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.
Mol Cancer Res
; 13(3): 493-501, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25351767